Fanwood, NJ, United States of America

Rose M Cubbon

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 12.8

ph-index = 5

Forward Citations = 365(Granted Patents)


Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Journey of Rose M. Cubbon

Introduction

Rose M. Cubbon, an accomplished inventor based in Fanwood, New Jersey, has made significant contributions to the field of pharmaceuticals through her innovative work. With a total of eight patents to her name, Cubbon has focused her research on the development of antagonists targeting proprotein convertase subtilisin-kexin type 9 (PCSK9), which is crucial in the treatment of various health conditions linked to this protein.

Latest Patents

Among her latest patents are:

1. **1B20 PCSK9 Antagonists** - This patent discloses antagonists of human PCSK9 that are effective in inhibiting its function. The patent outlines the nucleic acids coding for these antagonists, along with vectors, host cells, and related compositions. It also includes methods for creating PCSK9-specific antagonists and their application for inhibiting or antagonizing PCSK9 function.

2. **AX132 PCSK9 Antagonists** - Similar to her previous patent, this invention pertains to PCSK9 antagonists that can effectively inhibit PCSK9 function. It provides detailed descriptions of nucleic acids encoding these antagonists, as well as methods for their production and usage.

Career Highlights

Rose M. Cubbon has had an illustrious career at renowned institutions such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. Her extensive experience in the pharmaceutical industry has allowed her to play a pivotal role in the development of innovative medical solutions.

Collaborations

Throughout her career, Rose has collaborated with noted professionals, including colleagues Jon H. Condra and Laurence B. Peterson. These collaborations have further enhanced her research and have contributed to the advancement of her groundbreaking work in the field of PCSK9 antagonism.

Conclusion

Rose M. Cubbon stands out as a remarkable inventor in the realm of drug development. With her innovative research, particularly in the area of PCSK9 antagonists, she continues to pave the way for new therapeutic approaches to treat conditions associated with PCSK9 activity. Her career exemplifies dedication to innovation and collaboration in the pursuit of improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…